The degree of survivin depletion in many cell lines achieved with dn-ATF5 (in some cases, >90%) was on the order reached by survivin si- or sh-RNA treatments that elicit apoptotic tumor cell death. The gene discussed is BIRC5; the disease is neoplasm.